These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9091810)

  • 1. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.
    Katz MH; Gerberding JL
    N Engl J Med; 1997 Apr; 336(15):1097-100. PubMed ID: 9091810
    [No Abstract]   [Full Text] [Related]  

  • 2. Zidovudine against mother-to-child HIV transmission.
    Colebunders R; Coppieters Y
    Trop Med Int Health; 1999 Mar; 4(3):237-8. PubMed ID: 10223222
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of mother-child HIV transmission: a shortened and simplified zidovudine treatment].
    Sante; 2000; 10(6):406. PubMed ID: 11345936
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug could slash rate of perinatal HIV.
    Nature; 1999 Jul; 400(6742):304. PubMed ID: 10432101
    [No Abstract]   [Full Text] [Related]  

  • 5. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
    Kahn JO; Martin JN; Roland ME; Bamberger JD; Chesney M; Chambers D; Franses K; Coates TJ; Katz MH
    J Infect Dis; 2001 Mar; 183(5):707-14. PubMed ID: 11181146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
    Thaineua V; Sirinirund P; Tanbanjong A; Lallemant M; Soucat A; Lamboray JL
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):429-42. PubMed ID: 10437936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC considers 'morning after' therapy for sexual exposure. Centers for Disease Control and Prevention.
    AIDS Policy Law; 1997 Jun; 12(12):4. PubMed ID: 11364408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early treatment of sexual exposure to human immunodeficiency virus].
    Derancourt C; Drobacheff C; Verraes S; Beguinot I; Bernard P
    Ann Dermatol Venereol; 2000 Jan; 127(1):122-4. PubMed ID: 10717578
    [No Abstract]   [Full Text] [Related]  

  • 10. Postexposure treatment of HIV.
    Pinkerton SD; Holtgrave DR; Bloom FR
    N Engl J Med; 1997 Aug; 337(7):500-1. PubMed ID: 9254338
    [No Abstract]   [Full Text] [Related]  

  • 11. Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.
    Roland ME; Martin JN; Grant RM; Hellmann NS; Bamberger JD; Katz MH; Chesney M; Franses K; Coates TJ; Kahn JO
    J Infect Dis; 2001 Dec; 184(12):1608-12. PubMed ID: 11740738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-occupational postexposure HIV prophylaxis: clinical issues and public health questions.
    Mayer KH; Kwong J; Singal R; Boswell S
    Med Health R I; 2000 Jul; 83(7):210-3. PubMed ID: 10934823
    [No Abstract]   [Full Text] [Related]  

  • 13. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States.
    Pinkerton SD; Holtgrave DR; Layde PM
    Prev Med; 2000 Jan; 30(1):64-9. PubMed ID: 10642461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postexposure prophylaxis for nonoccupational HIV exposure.
    Ball SC
    AIDS Read; 2004 Nov; 14(11):587-8, 593-4. PubMed ID: 15570670
    [No Abstract]   [Full Text] [Related]  

  • 15. Opening the AIDS door.
    Kidson C
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):427-8. PubMed ID: 10437935
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
    Stiehm ER; Lambert JS; Mofenson LM; Bethel J; Whitehouse J; Nugent R; Moye J; Glenn Fowler M; Mathieson BJ; Reichelderfer P; Nemo GJ; Korelitz J; Meyer WA; Sapan CV; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H
    J Infect Dis; 1999 Mar; 179(3):567-75. PubMed ID: 9952362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya.
    Songok EM; Fujiyama Y; Tukei PM; Vulule JM; Kiptoo MK; Adungo NO; Kakimoto K; Kobayashi N; Genga IO; Mpoke S; Ichimura H
    Am J Trop Med Hyg; 2003 Jul; 69(1):8-13. PubMed ID: 12932089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study follows PEP for sexual exposures.
    AIDS Alert; 1998 Sep; 13(9):106-7. PubMed ID: 11365790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postexposure treatment of HIV--taking some risks for safety's sake.
    Henderson DK
    N Engl J Med; 1997 Nov; 337(21):1542-3. PubMed ID: 9366587
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy & perinatal transmission update.
    Denison R
    WORLD; 1998 Sep; (89):6-7. PubMed ID: 11365771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.